Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles

被引：0
|
作者：
Xingyang Yi
Qiang Zhou
Chun Wang
Jing Lin
Zhenxiao Chai
机构：
[1] People’s Hospital of Deyang City,Department of Neurology
[2] The Third Affiliated Hospital of Wenzhou Medical University,Department of Neurology
来源：
Journal of Neurology | 2018年 / 265卷
关键词：
Early neurological deterioration; Ischemic stroke; Clopidogrel; polymorphism; Dual antiplatelet therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2396 / 2403
页数：7
相关论文
共 50 条
  • [41] Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel
    Sun, Wenshan
    Li, Yongkun
    Li, Junrong
    Zhang, Zhizhong
    Zhu, Wusheng
    Liu, Wenhua
    Cai, Qiankun
    Wang, Xiaomeng
    Cao, Liping
    Bai, Wen
    Fan, Xinying
    Ma, Minmin
    Guo, Ruibing
    Liu, Xinfeng
    Xu, Gelin
    PLATELETS, 2015, 26 (06) : 558 - 562
  • [42] CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel
    Ramste, Markus
    Ritvos, Markus
    Hayrynen, Sergei
    Kiiski, Johanna I.
    Niemi, Mikko
    Sinisalo, Juha
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 2010 - 2020
  • [43] Non-Carriers of Reduced-Function CYP2C19 Alleles are Most Susceptible to Impairment of the Anti-Platelet Effect of Clopidogrel by Proton-Pump Inhibitors: A Pilot Study
    Lee, Jen-Kuang
    Wu, Cho-Kai
    Juang, Jyh-Ming
    Tsai, Chia-Ti
    Hwang, Juey-Jen
    Lin, Jiuun-Lee
    Chiang, Fu-Tien
    ACTA CARDIOLOGICA SINICA, 2016, 32 (02) : 215 - 222
  • [44] Non-carriers of reduced-function CYP2C19 alleles are most susceptible to the impairment of the anti-platelet effect of clopidogrel by concomitant use of proton-pump inhibitor
    Lee, J. K.
    Huang, W. H.
    Chiang, F. T.
    EUROPEAN HEART JOURNAL, 2010, 31 : 619 - 619
  • [45] A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users
    Osnabrugge, Ruben L.
    Head, Stuart J.
    Zijlstra, Felix
    ten Berg, Jurrien M.
    Hunink, Myriam G.
    Kappetein, A. Pieter
    Janssens, A. Cecile J. W.
    GENETICS IN MEDICINE, 2015, 17 (01) : 3 - 11
  • [46] Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response
    Han, Yan
    Lv, Hui-Hui
    Liu, Xu
    Dong, Qiang
    Yang, Xiao-Li
    Li, Shi-Xu
    Wu, Shuai
    Jiang, Jian-Ming
    Luo, Zheng
    Zhu, De-Sheng
    Zhang, Yi
    Zheng, Yi
    Guan, Yang-Tai
    Xu, Jian-Feng
    CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (09) : 692 - 697
  • [47] CYP2C19 loss-of-function alleles: A common but overlooked problem associated with clopidogrel resistance
    Chi, Nai-Fang
    Wang, Shuu-Jiun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (10)
  • [48] Comparison of ticagrelor and clopidogrel in the treatment of patients with coronary heart disease carrying CYP2C19 loss of function allele
    Qian, Wenwen
    Chen, Liang
    Zhang, Lizhu
    Gao, Mingzhu
    Wang, Chunxia
    Qian, Xi
    Yang, Chengjian
    Lin, Yahui
    Han, Zhijun
    JOURNAL OF THORACIC DISEASE, 2022, : 2591 - 2601
  • [49] PHARMACOGENOMICS IN STROKE: CYP2C19 LOSS-OF-FUNCTION IS ASSOCIATED WITH INCREASED RISK OF ISCHEMIC STROKE FOR CAROTID ARTERY STENOSIS PATIENTS
    Patel, P.
    Niu, X.
    Shannon, C.
    Fusco, M.
    Chitale, R.
    Peterson, J.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 80 - 80
  • [50] CYP2C19*17 polymorphism in stroke or transient ischemic event patients
    Diaz-Villamarin, X.
    Davila-Fajardo, C. L.
    Blanquez-Martinez, D.
    Leno-Duran, E.
    Antunez-Rodriguez, A.
    Perez-Campos, M.
    Cano-Talavera, I.
    Herrera-Trigueros, R.
    Alvarez-Sanchez, R.
    Martinez-Gonzalez, L. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 315 - 315
12345